Cargando…
Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
SIMPLE SUMMARY: Breast cancer is a leading cause of morbidity and mortality in women worldwide, with mortality rates largely driven by metastatic disease. Despite concerted efforts to uncover and target the mechanisms underlying these events, the five-year relative survival rate for metastatic breas...
Autores principales: | Duan, Suzann, Buxton, Iain L. O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140094/ https://www.ncbi.nlm.nih.gov/pubmed/35626053 http://dx.doi.org/10.3390/cancers14102450 |
Ejemplares similares
-
Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer
por: Duan, Suzann, et al.
Publicado: (2021) -
Extracellular NM23 Signaling in Breast Cancer: Incommodus Verum
por: Buxton, Iain L.O., et al.
Publicado: (2011) -
NF‐κB/NKILA signaling modulates the anti‐cancerous effects of EZH2 inhibition
por: Duan, Suzann, et al.
Publicado: (2019) -
Prominent role of histone lysine demethylases in cancer epigenetics and therapy
por: Janardhan, Avilala, et al.
Publicado: (2018) -
APOBEC3A is a prominent cytidine deaminase in breast cancer
por: Cortez, Luis M., et al.
Publicado: (2019)